{"_buckets": {"deposit": "5ad62b65-ef80-4e9f-9752-f92fb7d8f00a"}, "_deposit": {"id": "21089", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "21089"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:00021089"}, "item_9_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2015-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "4", "bibliographicPageEnd": "646", "bibliographicPageStart": "637", "bibliographicVolumeNumber": "77", "bibliographic_titles": [{"bibliographic_title": "Nagoya Journal of Medical Science"}]}]}, "item_9_description_4": {"attribute_name": "\u6284\u9332", "attribute_value_mlt": [{"subitem_description": "The purposes of this study on prostate cancer are to demonstrate the time course of International Prostate Symptom Score (IPSS) after intensity-modulated radiation therapy (IMRT) combined with androgen deprivation therapy (ADT) and to examine the factor associated with the IPSS change. This study included 216 patients treated with IMRT between 2006 and 2010. Patients were evaluated in three groups according to baseline IPSS as defined by the American Urological Association classification, where IPSSs of 0 to 7, 8 to 19, and 20 to 35 represent mild (n = 124), moderate (n = 70), and severe (n = 22) symptom groups, respectively. The average IPSSs \u00b1 standard deviation at baseline vs. those at 24 months after IMRT were 3.5 \u00b1 2.1 vs. 5.1 \u00b1 3.6 in the mild group (P \u003c 0.001), 12.6 \u00b1 3.4 vs. 10.0 \u00b1 6.0 in the moderate group (P = 0.0015), and 23.8 \u00b1 2.9 vs. 14.4 \u00b1 9.1 in the severe group (P \u003c 0.001). Among factors of patient and treatment characteristics, age, IPSS classification, pretreatment GU medications, and positive biopsy rates were associated with the IPSS difference between baseline and 24 months (P = 0.023, \u003c 0.001, 0.044, and 0.028, respectively). In conclusion, patients with moderate to severe urinary symptoms can exhibit improvement in urinary function after IMRT, whereas patients with mild symptoms may have slightly worsened functions. Age, baseline IPSS, GU medications, and tumor burden in the prostate can have an effect on the IPSS changes.", "subitem_description_type": "Abstract"}]}, "item_9_identifier_60": {"attribute_name": "URI", "attribute_value_mlt": [{"subitem_identifier_type": "URI", "subitem_identifier_uri": "http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/774.html"}, {"subitem_identifier_type": "HDL", "subitem_identifier_uri": "http://hdl.handle.net/2237/23228"}]}, "item_9_identifier_registration": {"attribute_name": "ID\u767b\u9332", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.18999/nagjms.77.4.637", "subitem_identifier_reg_type": "JaLC"}]}, "item_9_publisher_32": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "Nagoya University Graduate School of Medicine, School of Medicine"}]}, "item_9_select_15": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_9_source_id_7": {"attribute_name": "ISSN\uff08print\uff09", "attribute_value_mlt": [{"subitem_source_identifier": "0027-7622", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Tomita, Natsuo"}], "nameIdentifiers": [{"nameIdentifier": "60991", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Oze, Isao"}], "nameIdentifiers": [{"nameIdentifier": "60992", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shimizu, Hidetoshi"}], "nameIdentifiers": [{"nameIdentifier": "60993", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yoshida, Maiko"}], "nameIdentifiers": [{"nameIdentifier": "60994", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kimura, Kana"}], "nameIdentifiers": [{"nameIdentifier": "60995", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takehana, Keiichi"}], "nameIdentifiers": [{"nameIdentifier": "60996", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shimizu, Arisa"}], "nameIdentifiers": [{"nameIdentifier": "60997", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Makita, Chiyoko"}], "nameIdentifiers": [{"nameIdentifier": "60998", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tachibana, Hiroyuki"}], "nameIdentifiers": [{"nameIdentifier": "60999", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kodaira, Takeshi"}], "nameIdentifiers": [{"nameIdentifier": "61000", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Soga, Norihito"}], "nameIdentifiers": [{"nameIdentifier": "61001", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ogura, Yuji"}], "nameIdentifiers": [{"nameIdentifier": "61002", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hayashi, Norio"}], "nameIdentifiers": [{"nameIdentifier": "61003", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-02-21"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "19_Tomita.pdf", "filesize": [{"value": "220.4 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 220400.0, "url": {"label": "19_Tomita.pdf", "url": "https://nagoya.repo.nii.ac.jp/record/21089/files/19_Tomita.pdf"}, "version_id": "3a1a0d50-a31f-4c6e-9930-5836da894054"}]}, "item_keyword": {"attribute_name": "\u30ad\u30fc\u30ef\u30fc\u30c9", "attribute_value_mlt": [{"subitem_subject": "IPSS", "subitem_subject_scheme": "Other"}, {"subitem_subject": "prostate cancer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "genitourinary toxicity", "subitem_subject_scheme": "Other"}, {"subitem_subject": "IMRT", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ADT", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "International prostate symptom score (IPSS) change and changing factor in intensity-modulated radiotherapy combined with androgen deprivation therapy for prostate cancer", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "International prostate symptom score (IPSS) change and changing factor in intensity-modulated radiotherapy combined with androgen deprivation therapy for prostate cancer"}]}, "item_type_id": "9", "owner": "1", "path": ["499/508/509/1807"], "permalink_uri": "https://doi.org/10.18999/nagjms.77.4.637", "pubdate": {"attribute_name": "\u516c\u958b\u65e5", "attribute_value": "2015-11-24"}, "publish_date": "2015-11-24", "publish_status": "0", "recid": "21089", "relation": {}, "relation_version_is_last": true, "title": ["International prostate symptom score (IPSS) change and changing factor in intensity-modulated radiotherapy combined with androgen deprivation therapy for prostate cancer"], "weko_shared_id": null}